Six Years Follow-Up of an 11-Year-Old Girl with Anti-HMGCR Myopathy

Creative Commons License

Cavusoglu D., TALİM B., Ekinci G., Topaloglu H.

JOURNAL OF NEUROMUSCULAR DISEASES, vol.11, no.4, pp.883-887, 2024 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 4
  • Publication Date: 2024
  • Doi Number: 10.3233/jnd-240022
  • Journal Name: JOURNAL OF NEUROMUSCULAR DISEASES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, MEDLINE
  • Page Numbers: pp.883-887
  • Hacettepe University Affiliated: Yes

Abstract

. Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level. In pediatric population, antiHMGCR myopathy has been reported solely as small case reports, albeit rare. Although treatment consensus has not yet been established, proper treatment with several immunomodulators to include IVIg can show remarkable improvement. We report an 11-year-old-girl diagnosed with anti-HMGCR myopathy with 6 years of follow-up.